Reset filter
Keywords
Orzecznictwo lekarskie ×
Mostra di più Keywords
Sommario
  1. 1. Essai clinique
  2. 2. Routinedokumentation
  3. 3. Études de registres/cohortes
  4. 4. Assurance qualité
  5. 5. Standard de données
  6. 6. Questionnaire pour les patients
  7. 7. Spécialité médicale
    1. 7.1. Anesthésie
    1. 7.2. Dermatologie
    1. 7.3. HNO
    1. 7.4. Gériatrie
    1. 7.5. Gynécologie/obstétrique
    1. 7.6. Médecine interne
      1. Hématologie
      1. Infectiologie
      1. Cardiologie/angiologie
      1. Pneumologie
      1. Gastroentérologie
      1. Néphrologie
      1. Endocrinologie/métabolisme
      1. Rhumatologie
    1. 7.7. Neurologie
    1. 7.8. Ophtalmologie
    1. 7.9. Médecine palliative
    1. 7.10. Pathologie/médécine légale
    1. 7.11. Pédiatrie
    1. 7.12. Psychiatrie/psychosomatique
    1. 7.13. Radiologie
    1. 7.14. Chirurgie
      1. Chirurgie générale/viscérale
      1. Neurochirurgie
      1. Chirurgie plastique
      1. Chirurgie cardiaque/thoracique
      1. Chirurgie traumatologique/orthopédie
      1. Chirurgie vasculaire
    1. 7.15. Urologie
    1. 7.16. Médecine dentaire/MKG
Modelli di dati selezionati

Devi effettuare il log in per selezionare i modelli di dati da scaricare per successive analisi

85 Risultati di ricerca.
rilevanza Valutazione Più recente Meno recente

Eligibility DRKS00005561 NCT00508664 Squamous Cell Carcinoma of the Hypopharynx - Eligibility

- 20/09/2021 - 1 modulo, 2 itemgroups, 31 elementi, 2 lingue
Itemgroups: Inclusion Criteria, Exclusion Criteria
ODM derived from http://clinicaltrials.gov/show/NCT00508664

Eligibility Head and Neck Cancer NCT02124707

- 02/02/2020 - 1 modulo, 2 itemgroups, 13 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN; ODM derived from: https://clinicaltrials.gov/show/NCT02124707

Eligibility Head and Neck Cancer NCT00670397

- 02/02/2020 - 1 modulo, 1 ItemGroup, 19 elementi, 1 linguaggio
ItemGroup: Criteria
Photodynamic Therapy Using HPPH in Treating Patients With Recurrent Dysplasia, Carcinoma in Situ, or Stage I Oral Cavity Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00670397

Eligibility Head and Neck Cancer NCT02442739

- 02/04/2019 - 1 modulo, 2 itemgroups, 22 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety Study of Ketamine for Preventing Depression in Patients Undergoing Treatment for Head and Neck Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02442739

Eligibility Head and Neck Cancer NCT02410382

- 01/04/2019 - 1 modulo, 2 itemgroups, 16 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Dexamethasone for Treatment of Radiation-related Fatigue in Patients Receiving RT for Head-neck and Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02410382

Eligibility Recurrent Head and Neck Cancer NCT02289209

- 27/06/2019 - 1 modulo, 2 itemgroups, 19 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Reirradiation With MK-3475 in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck; ODM derived from: https://clinicaltrials.gov/show/NCT02289209

Eligibility Papillary Thyroid Cancer NCT01974284

- 05/06/2019 - 1 modulo, 2 itemgroups, 14 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01974284

Eligibility Stage I Papillary Thyroid Cancer NCT02138214

- 17/09/2021 - 1 modulo, 2 itemgroups, 16 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Thyroid Gland Removal With or Without Central Lymph Node Dissection in Treating Patients With Node Negative Thyroid Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02138214

Eligibility Low-risk Papillary Thyroid Cancer NCT02408887

- 29/04/2019 - 1 modulo, 2 itemgroups, 17 elementi, 1 linguaggio
Itemgroups: Criteria, Exclusion Criteria
Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02408887

Eligibility Carcinoma NCT00243347

- 25/01/2017 - 1 modulo, 2 itemgroups, 13 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00243347

Eligibility Cancer of the Head and Neck NCT00180921

- 21/07/2016 - 1 modulo, 2 itemgroups, 14 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and Neck; ODM derived from: https://clinicaltrials.gov/show/NCT00180921

Eligibility Head and Neck Cancer NCT01958515

- 31/08/2015 - 1 modulo, 2 itemgroups, 11 elementi, 1 linguaggio
Itemgroups: Inclusion Criteria, Exclusion Criteria
Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation; ODM derived from: https://clinicaltrials.gov/show/NCT01958515

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial